1. The Research on the Treatment of Metastatic Skin Cutaneous Melanoma by Huanglian Jiedu Decoction Based on the Analysis of Immune Infiltration Analysis
    Ding Li et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
  2. Antitumor activity of flavonoids from Alpinia officinarum hance on gastric cancer
    Mirensha Yakufu et al, 2021, Eur J Inflamm CrossRef
  3. STAT3-EMT axis in tumors: modulation of cancer metastasis, stemness and therapy response
    Mehrdokht Sadrkhanloo et al, 2022, Pharmacological Research CrossRef
  4. Advances in the synergistic and toxic attenuating effect of traditional Chinese medicine in cancer treatment
    Jiao CHEN et al, 2022, Sci. Sin.-Vitae CrossRef
  5. Research Status of Mouse Models for Non-Small-Cell Lung Cancer (NSCLC) and Antitumor Therapy of Traditional Chinese Medicine (TCM) in Mouse Models
    Hongkui Chen et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
  6. Reduction in gefitinib resistance mediated by Yi-Fei San-Jie pill in non-small cell lung cancer through regulation of tyrosine metabolism, cell cycle, and the MET/EGFR signaling pathway
    Cai-Zhi Yang et al, 2023, Journal of Ethnopharmacology CrossRef
  7. Traditional Chinese medicines for non-small cell lung cancer: Therapies and mechanisms
    Fanming Kong et al, 2023, Chinese Herbal Medicines CrossRef
  8. Flavonoids as receptor tyrosine kinase inhibitors in lung cancer
    Sareshma Sudhesh Dev et al, 2023, Journal of Functional Foods CrossRef
  9. Oligonucleotide-Based Therapeutics for STAT3 Targeting in Cancer—Drug Carriers Matter
    Sara Molenda et al, 2023, Cancers CrossRef
  10. The cell line models to study tyrosine kinase inhibitors in non-small cell lung cancer with mutations in the epidermal growth factor receptor: a scoping review.
    Alessia Belloni et al, 2023, Critical Reviews in Oncology/Hematology CrossRef
  11. Strategies for Enhancing Non-small Cell Lung Cancer Treatment: Integrating Chinese Herbal Medicines with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors Therapy
    Lin Chen et al, 2024, European Journal of Pharmacology CrossRef